OTITIS MEDIA: A CLINICAL ASSESSMENT OF ETIOLOGICAL PATHOGENS, SUSCEPTIBILITY STATUS AND AVAILABLE THERAPEUTIC OPTIONS AMONG 19 ANTIBACTERIAL AGENTS IN MAIDUGURI-CITY, NIGERIA
*John David, OHIEKU and Funsho Emmanuel, FAKUADE
Department of Clinical Pharmacy and Pharmacy Administration, Faculty of Pharmacy, University of Maiduguri, PMB 1069, Maiduguri, Borno State, Nigeria.
ABSTRACT
Patients with Otitis Media were assessed for etiological pathogens and
their susceptibility status to evaluate available anti-bacterial treatment
options. 125 patients (69 males and 56 females) were studied with 107
(85.6%) showing laboratory evidence of the disease. Children below 2
years had the highest cases (45.8%) while others include: preschool
age (18.7%), school age group (8.4%), teenage group (3.7%), adults
(22.5%) and the geriatrics (0.94%). Otitis Media conditions were
higher in the male (55.2%) than the female subjects (44.8%). The
isolated pathogens were Pseudomonas spp (42.7%), Staphylococcus
aureus (21.4%), Klebsiella spp (13.7%), Proteus spp (11.9%),
Escherichia coli (8.6%) and Streptococcus spp (1.7%). Pseudomonas
spp sensitivities were ciprofloxacin (92%), pefloxacin (81.4%),
ofloxacin (86.4%), streptomycin (81.3%), ceftriaxone (100%) and
azithromycin (100%) but recorded high resistance to co-trimoxazole
(90.9%), ampicillin (90.5%) and amoxicillin/clavulanic acid (75.6%). Staph aureus showed
sensitivities to rifampicin (90.9%), levofloxacin (100%), cefuroxime (100%) and gentamicin
(83.3%) with ampicillin/cloxacillin recording the least (15.8%). Klebsiella spp showed the
highest susceptibility to ofloxacin (92.9%) and streptomycin (80%) but activities of cotrimoxazole
(30.8%), ampicillin (15.4%) and nalidixic acid (7.7%) were recorded against
Proteus spp in contrast to the 100%, 91.7% and 75% activities recorded by ceftrioxone, pefloxacin and streptomycin respectively. E. coli showed 100% sensitivity to ofloxacin but
indicated high resistances to ampicillin (70%), co-trimoxazole (80%) and
amoxicillin/clavulanic acid (80). Several agents have promising ex-vivo activities against
many pathogens but there are few treatment options because of the limited applications of the
fluoroquinolones in children, the potential ototoxicity of the aminoglycosides, the high
resistance rates of many agents and the high costs/parenteral dosage forms of others.
Keywords: Fluoroquinolones, Pseudomonas, Otitis media, pathogens, Resistance, Maiduguri-city.
[Download Article]
[Download Certifiate]